Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Recruiting
Observational Study
Intracranial Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 4 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 199 (estimated)
- Sponsor
- Thomas Hope · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a single center study investigating the use of Fluoroethyltyrosine (FET) in the detection of brain tumors. FET accumulates in malignant cells within intracranial neoplasms and can be used to detect recurrent disease and characterize grade of glial neoplasms.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Presence or suspicion of intracranial neoplasm in two populations:
* Population 1: Participants after primary treatment (radiation therapy and/or surgery) with suspicion of recurrence on MRI.
* Three sub-populations will be considered:
* Recurrent metastatic lesions.…
Contacts